Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease (FUNGRAPE)
This study has been completed.
Sponsor:
National Research Council, Spain
Collaborator:
University Hospital Morales Meseguer (Murcia, Spain)
Information provided by (Responsible Party):
Juan Carlos Espín de Gea, National Research Council, Spain
ClinicalTrials.gov Identifier:
NCT01449110
First received: October 6, 2011
Last updated: November 15, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2011 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |